| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | General Counsel | Ordinary Shares | 174,573 | $1,918,557 | $10.99 | 31 Dec 2025 | Direct |
| NovoCure Ltd | General Counsel | Stock Options (Right to buy) | 81,499 | $1,482,467 | $18.19 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | 31 Dec 2025 | 1 | +$1,187 | 5 | General Counsel | 08 Jan 2026, 16:21 |
| NVCR | NovoCure Ltd | 30 Jun 2025 | 1 | +$11,635 | 4 | General Counsel | 01 Jul 2025, 16:19 |
| NVCR | NovoCure Ltd | 04 Mar 2025 | 2 | +$2,482,462 | 4 | General Counsel | 06 Mar 2025, 16:42 |
| NVCR | NovoCure Ltd | 31 Dec 2024 | 1 | +$9,866 | 4 | General Counsel | 03 Jan 2025, 16:04 |
| NVCR | NovoCure Ltd | 28 Jun 2024 | 1 | +$11,383 | 4 | General Counsel | 06 Aug 2024, 16:22 |
| NVCR | NovoCure Ltd | 27 Feb 2024 | 3 | +$3,373,719 | 4 | General Counsel | 29 Feb 2024, 16:30 |
| NVCR | NovoCure Ltd | 30 Jun 2023 | 1 | +$10,161 | 4 | General Counsel | 06 Jul 2023, 16:13 |
| NVCR | NovoCure Ltd | 28 Feb 2023 | 2 | +$2,273,001 | 4 | General Counsel | 02 Mar 2023, 15:56 |
| NVCR | NovoCure Ltd | 06 Jan 2023 | 1 | +$9,346 | 4 | General Counsel | 10 Jan 2023, 15:20 |
| NVCR | NovoCure Ltd | 05 Jul 2022 | 1 | +$8,507 | 4 | General Counsel | 07 Jul 2022, 17:50 |
| NVCR | NovoCure Ltd | 14 Apr 2022 | 0 | $0 | 3 | General Counsel | 14 Apr 2022, 16:36 |